Clinical Trial Update: Trial of Pemetrexed and Carboplatin in Patients With Recurrent Ovarian or Primary Peritoneal Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating pemetrexed in combination with carboplatin in patients with recurrent ovarian cancer or primary peritoneal cancer has completed, with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Alimta (pemetrexed)
• CARBOPLATIN (Carboplatin)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Ovarian Cancer, Primary Peritoneal Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2011-06-16